Related Experiment Video
Updated: Feb 11, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
Lack Of Diversity In Genomic Databases Is A Barrier To Translating Precision Medicine Research Into Practice
Latrice G Landry1, Nadya Ali2, David R Williams3
1Latrice G. Landry ( Latrice_Landry@hms.harvard.edu ) is a fellow in the Laboratory for Molecular Medicine, Partners Personalized Medicine, in Cambridge, Massachusetts, and in the Office of Minority Health, Food and Drug Administration, in Silver Spring, Maryland.
Genomic studies lack diversity, with underrepresentation of African, Latin American, and Asian populations compared to European groups. This disparity challenges the equitable promise of precision medicine for all patient groups.
Area of Science:
- Genomics
- Biomedical Research
- Health Disparities
Background:
- Precision medicine aims to tailor treatments using molecular biomarkers for improved patient outcomes.
- Underrepresentation of diverse populations in genomic research poses a significant challenge to equitable biomarker application.
- Existing genomic databases show disparities in the inclusion of various ancestral groups.
Purpose of the Study:
- To assess population diversity in genomic studies.
- To identify representation gaps in public genomic databases.
Main Methods:
- Analysis of studies cataloged in the Genome-Wide Association Study (GWAS) Catalog.
- Examination of data within the database of Genotypes and Phenotypes (dbGaP).
- Comparison of study inclusion rates across different ancestral populations (European, African, Latin American, Asian).
Main Results:
- Genomic studies significantly underrepresent African, Latin American, and Asian populations compared to European populations.
- This underrepresentation is consistent across different data types and disease areas within the analyzed databases.
- While there is a modest increase in studies including non-European populations, the overall numbers remain low.
Conclusions:
- Current genomic research databases exhibit substantial ancestral population disparities.
- Decisive action is required to enhance diversity in genomic studies.
- Achieving the full potential of precision medicine necessitates equitable representation of all populations.
More Related Videos
Related Concept Videos
Genomics
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Termination of Translation
Genome Size and the Evolution of New Genes

